Columbia Laboratories, Inc. (NASDAQ:CBRX) Stock Quotes and News

Columbia Laboratories, Inc. (CBRX) 0.69 0.00

Price Open:	0.6099	Day's Range:	0.00000 - 1.24000
Price Close:	0.62	52wk Range:	0.00000 - 2.96
Price Day Change:	0.00	Volume:	143,722
Price % Change:	0.00	Market Cap:	54.3M
Bid:	0.59010	PE Ratio:	11.70
Ask:	0.68500	EPS Diluted:	0.053

Trade CBRX NOW!

The Latest On CBRX

A Peek Into The Market Before The Trading Starts 4/9/13 7:26am

Columbia Laboratories Amends License Agreement with Merck Serono for CRINONE Ex-US to 2020 4/9/13 6:56am

Earnings Scheduled For March 14, 2013 3/14/13 4:25am

Columbia Labs Extends Holder Rights Plan to Preserve Use of Net Oper. Loss 3/6/13 8:07am

Columbia Laboratories Extends Stockholder Rights Plan 3/6/13 7:58am

Jonathan B. Lloyd Jones Named of Columbia Laboratories CFO 1/16/13 7:52am

Columbia Laboratories Confirms FDA Denies Watson's Appeal Related to Prochieve NDA for the Prevention of Preterm Birth 10/26/12 8:38am

Columbia Laboratories Receives Nasdaq Non-compliance Letter 10/25/12 6:38am

A Peek Into The Market Before The Trading Starts 3/13/12 7:18am

Columbia Laboratories Hires Cowen and Company to Assist in Evaluating Potential Strategic Transactions 3/13/12 6:57am

Columbia Laboratories Announces 42% Workforce Reduction; To Save $1.5M Annually 3/1/12 5:00pm

Morning Social Media Outlook for Monday Feb 27 (LNG, CBRX, OME, LUV) 2/27/12 12:36pm

Press Releases

Columbia Laboratories to Discuss First Quarter 2013 Financial Results on May 9 Conference Call 4/25/13 Business Wire

Columbia Laboratories Reports Fourth Quarter and Year-End 2012 Financial Results 3/14/13 Business Wire

Columbia Laboratories Extends Stockholder Rights Plan to Preserve Use of Net Operating Losses under Section 382 3/6/13 Business Wire

Columbia Laboratories to Discuss Fourth Quarter and Year-End 2012 Financial Results on March 14 Conference Call 3/4/13 Business Wire

Columbia Laboratories to Present March 6th at Cowen and Company Health Care Conference 2/28/13 Business Wire

Jonathan B. Lloyd Jones Appointed CFO of Columbia Laboratories 1/16/13 Business Wire

Get the latest CBRX stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Columbia Laboratories, Inc. stock price.

Partner Headlines

Merck KGaA-CBRX Renew Agreement - Analyst Blog 4/11/13

Buried Treasures: LPHI, MM, and CBRX are Dug Up and Examined 10/24/12

What to Do With Envivio, Nam Tai Electronics, and Columbia Laboratories Now (ENVI, CBRX, NTE) 8/30/12

The Time to Strike is When the Iron is Hot: Biotech Stocks SVNT, CBRX, KERX in Focus 8/21/12

Columbia Laboratories Inc. Reports Operating Results (10-Q) 8/8/12

Overland Storage, Columbia Laboratories Gapping Up Monday 6/25/12

Columbia Laboratories Inc. Reports Operating Results (10-Q) 5/4/12

Columbia Laboratories Inc. Reports Operating Results (10-K) 3/12/12

FDA Issues CRL for Watson's Drug - Analyst Blog 3/1/12

Update on Watson's Candidate - Analyst Blog 2/15/12

Watson's Drug Fails to Get Support - Analyst Blog 1/23/12